These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 34282144)
1. Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-like disease. Ban T; Kikuchi M; Sato GR; Manabe A; Tagata N; Harita K; Nishiyama A; Nishimura K; Yoshimi R; Kirino Y; Yanai H; Matsumoto Y; Suzuki S; Hihara H; Ito M; Tsukahara K; Yoshimatsu K; Yamamoto T; Taniguchi T; Nakajima H; Ito S; Tamura T Nat Commun; 2021 Jul; 12(1):4379. PubMed ID: 34282144 [TBL] [Abstract][Full Text] [Related]
2. Lyn Kinase Suppresses the Transcriptional Activity of IRF5 in the TLR-MyD88 Pathway to Restrain the Development of Autoimmunity. Ban T; Sato GR; Nishiyama A; Akiyama A; Takasuna M; Umehara M; Suzuki S; Ichino M; Matsunaga S; Kimura A; Kimura Y; Yanai H; Miyashita S; Kuromitsu J; Tsukahara K; Yoshimatsu K; Endo I; Yamamoto T; Hirano H; Ryo A; Taniguchi T; Tamura T Immunity; 2016 Aug; 45(2):319-32. PubMed ID: 27521268 [TBL] [Abstract][Full Text] [Related]
3. Regulation and role of the transcription factor IRF5 in innate immune responses and systemic lupus erythematosus. Ban T; Sato GR; Tamura T Int Immunol; 2018 Oct; 30(11):529-536. PubMed ID: 29860420 [TBL] [Abstract][Full Text] [Related]
4. Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus. Savitsky DA; Yanai H; Tamura T; Taniguchi T; Honda K Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10154-9. PubMed ID: 20479222 [TBL] [Abstract][Full Text] [Related]
5. IRF5 is elevated in childhood-onset SLE and regulated by histone acetyltransferase and histone deacetylase inhibitors. Shu J; Li L; Zhou LB; Qian J; Fan ZD; Zhuang LL; Wang LL; Jin R; Yu HG; Zhou GP Oncotarget; 2017 Jul; 8(29):47184-47194. PubMed ID: 28525378 [TBL] [Abstract][Full Text] [Related]
6. Interferon regulatory factor-5 deficiency ameliorates disease severity in the MRL/lpr mouse model of lupus in the absence of a mutation in DOCK2. Yasuda K; Watkins AA; Kochar GS; Wilson GE; Laskow B; Richez C; Bonegio RG; Rifkin IR PLoS One; 2014; 9(7):e103478. PubMed ID: 25076492 [TBL] [Abstract][Full Text] [Related]
7. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice. Tada Y; Kondo S; Aoki S; Koarada S; Inoue H; Suematsu R; Ohta A; Mak TW; Nagasawa K Arthritis Rheum; 2011 Mar; 63(3):738-48. PubMed ID: 21305501 [TBL] [Abstract][Full Text] [Related]
8. Distinct regulation of murine lupus susceptibility genes by the IRF5/Blimp-1 axis. Panchanathan R; Liu H; Liu H; Fang CM; Erickson LD; Pitha PM; Choubey D J Immunol; 2012 Jan; 188(1):270-8. PubMed ID: 22116829 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of IRF5 hyperactivation protects from lupus onset and severity. Song S; De S; Nelson V; Chopra S; LaPan M; Kampta K; Sun S; He M; Thompson CD; Li D; Shih T; Tan N; Al-Abed Y; Capitle E; Aranow C; Mackay M; Clapp WL; Barnes BJ J Clin Invest; 2020 Dec; 130(12):6700-6717. PubMed ID: 32897883 [TBL] [Abstract][Full Text] [Related]
10. Interferon regulatory factor 5 in the pathogenesis of systemic lupus erythematosus. Cham CM; Ko K; Niewold TB Clin Dev Immunol; 2012; 2012():780436. PubMed ID: 23251221 [TBL] [Abstract][Full Text] [Related]
11. IRF5-mediated signaling and implications for SLE. Lazzari E; Jefferies CA Clin Immunol; 2014 Aug; 153(2):343-52. PubMed ID: 24928322 [TBL] [Abstract][Full Text] [Related]
13. The Devaraju P; Mehra S; Gulati R; Antony PT; Jain VK; Misra DP; Negi VS Indian J Med Res; 2018 Jun; 147(6):560-566. PubMed ID: 30168487 [TBL] [Abstract][Full Text] [Related]
14. Interferon regulatory factor 5 and autoimmune lupus. Xu WD; Pan HF; Xu Y; Ye DQ Expert Rev Mol Med; 2013 Jul; 15():e6. PubMed ID: 23883595 [TBL] [Abstract][Full Text] [Related]
15. The genetics and biology of Irf5-mediated signaling in lupus. Kozyrev SV; Alarcon-Riquelme ME Autoimmunity; 2007 Dec; 40(8):591-601. PubMed ID: 18075793 [TBL] [Abstract][Full Text] [Related]
16. Monocytes from Irf5-/- mice have an intrinsic defect in their response to pristane-induced lupus. Yang L; Feng D; Bi X; Stone RC; Barnes BJ J Immunol; 2012 Oct; 189(7):3741-50. PubMed ID: 22933628 [TBL] [Abstract][Full Text] [Related]
17. A redundant epistatic interaction between IRF5 and STAT4 of the type I interferon pathway in susceptibility to lupus and rheumatoid arthritis. Kim K; Cho SK; Han TU; Kim JH; Kang SJ; Kang C; Bae SC Lupus; 2013 Nov; 22(13):1336-40. PubMed ID: 24014567 [TBL] [Abstract][Full Text] [Related]
18. Association of IRF5 polymorphisms with increased risk for systemic lupus erythematosus in population of Crete, a southern-eastern European Greek island. Zervou MI; Dorschner JM; Ghodke-Puranik Y; Boumpas DT; Niewold TB; Goulielmos GN Gene; 2017 Apr; 610():9-14. PubMed ID: 28185859 [TBL] [Abstract][Full Text] [Related]
20. Genetic Versus Non-genetic Drivers of SLE: Implications of IRF5 Dysregulation in Both Roads Leading to SLE. Barnes BJ Curr Rheumatol Rep; 2019 Jan; 21(1):2. PubMed ID: 30645688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]